Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2013

01-07-2013 | Original Article

Effect of Amiloride on Experimental Acid-Induced Heartburn in Non-erosive Reflux Disease

Authors: William J. Bulsiewicz, Nicholas J. Shaheen, Mark B. Hansen, Amy Pruitt, Roy C. Orlando

Published in: Digestive Diseases and Sciences | Issue 7/2013

Login to get access

Abstract

Background

Acid-sensing ion channels (ASICs) are esophageal nociceptors that are candidates to mediate heartburn in non-erosive reflux disease (NERD). Amiloride, a diuretic, is known to inhibit ASICs. For this reason, we sought a role for ASICs in mediating heartburn by determining whether amiloride could block heartburn in NERD induced by esophageal acid perfusion.

Methods

In a randomized double-blind crossover study, we perfused the esophagus with amiloride or (saline) placebo prior to eliciting acid-induced heartburn in patients with a history of proton pump inhibitor-responsive NERD. Those with NERD and positive modified Bernstein test were randomized to perfusion with amiloride, 1 mmol/l, or placebo for 5 min, followed by repeat acid-perfusion. Heartburn severity and time to onset was measured and the process repeated following crossover to the alternative agent.

Results

14 subjects completed the study. Amiloride did not reduce the frequency (100 vs. 100 %) or severity of acid-induced heartburn (Mean 2.50 ± SEM 0.33 vs. 2.64 ± 0.45), respectively. There was a trend towards longer time to onset of heartburn for amiloride versus placebo (Mean 2.93 ± SEM 0.3 vs. 2.36 ± 0.29 min, respectively), though these differences did not reach statistical significance (p > 0.05).

Conclusions

Amiloride had no significant effect on acid-induced heartburn frequency or severity in NERD, although there was a trend towards prolonged time to onset of symptoms.
Literature
1.
go back to reference Bhat YM, Bielefeldt K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol. 2006;18:263–270.PubMedCrossRef Bhat YM, Bielefeldt K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol. 2006;18:263–270.PubMedCrossRef
2.
3.
go back to reference Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol. 2004;16:897–902.PubMedCrossRef Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol. 2004;16:897–902.PubMedCrossRef
4.
go back to reference Page AJ, Brierley SM, Martin CM, et al. Different contributions of ASIC channels 1a, 2, 3 in gastrointestinal mechanosensory function. Gut. 2005;54:1408–1415.PubMedCrossRef Page AJ, Brierley SM, Martin CM, et al. Different contributions of ASIC channels 1a, 2, 3 in gastrointestinal mechanosensory function. Gut. 2005;54:1408–1415.PubMedCrossRef
5.
go back to reference Leffler A, Monter B, Koltzenburg M. The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICs) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice. Neuroscience. 2006;139:699–709.PubMedCrossRef Leffler A, Monter B, Koltzenburg M. The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICs) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice. Neuroscience. 2006;139:699–709.PubMedCrossRef
6.
go back to reference Kindt S, Vos R, Blondeau K, Tack J. Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man. Neurogastroenterol Motil. 2009;21:1032–e82.PubMed Kindt S, Vos R, Blondeau K, Tack J. Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man. Neurogastroenterol Motil. 2009;21:1032–e82.PubMed
7.
go back to reference Krarup AL, Ny L, Astrand M, et al. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther. 2011;33:1113–1122.PubMedCrossRef Krarup AL, Ny L, Astrand M, et al. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther. 2011;33:1113–1122.PubMedCrossRef
8.
go back to reference Ugawa S, Ueda T, Ishida Y, Nishigaki M, Shibata Y, Shimada S. Amiloride-blockable acid-sensing ion channels are leading acid sensors expressed in human nociceptors. J Clin Invest. 2002;110:1185–1190.PubMed Ugawa S, Ueda T, Ishida Y, Nishigaki M, Shibata Y, Shimada S. Amiloride-blockable acid-sensing ion channels are leading acid sensors expressed in human nociceptors. J Clin Invest. 2002;110:1185–1190.PubMed
9.
go back to reference Nuzum CT. Nasogastric intubation. In: Drossman DA, ed. Manual of Gastroenterologic Procedures. New York: Raven Press; 1982:11–15. Nuzum CT. Nasogastric intubation. In: Drossman DA, ed. Manual of Gastroenterologic Procedures. New York: Raven Press; 1982:11–15.
10.
go back to reference Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology. 1996;111:1200–1205.PubMedCrossRef Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology. 1996;111:1200–1205.PubMedCrossRef
11.
go back to reference Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13–22.PubMedCrossRef Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13–22.PubMedCrossRef
12.
go back to reference Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology. 2005;128:771–778.PubMedCrossRef Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology. 2005;128:771–778.PubMedCrossRef
13.
go back to reference Calabrese C, Bortolotti M, Fabbri A, et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol. 2005;100:537–542.PubMedCrossRef Calabrese C, Bortolotti M, Fabbri A, et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol. 2005;100:537–542.PubMedCrossRef
14.
go back to reference Kern M, Hofmann C, Hyde J, Shaker R. Characterization of the cerebral cortical representation of heartburn in GERD patients. Am J Physiol Gastrointest Liver Physiol. 2004;286:G174–G181.PubMedCrossRef Kern M, Hofmann C, Hyde J, Shaker R. Characterization of the cerebral cortical representation of heartburn in GERD patients. Am J Physiol Gastrointest Liver Physiol. 2004;286:G174–G181.PubMedCrossRef
15.
go back to reference Jones NG, Slater R, Cadiou H, McNaughton P, McMahon SB. Acid-induced pain and its modulation in humans. J Neurosci. 2004;24:10974–10979.PubMedCrossRef Jones NG, Slater R, Cadiou H, McNaughton P, McMahon SB. Acid-induced pain and its modulation in humans. J Neurosci. 2004;24:10974–10979.PubMedCrossRef
16.
go back to reference Awayda MS, Bengrine A, Tobey NA, Stockand JD, Orlando RC. Nonselective cation transport in native esophageal epithelia. Am J Physiol Cell Physiol. 2004;287:C395–C402.PubMedCrossRef Awayda MS, Bengrine A, Tobey NA, Stockand JD, Orlando RC. Nonselective cation transport in native esophageal epithelia. Am J Physiol Cell Physiol. 2004;287:C395–C402.PubMedCrossRef
Metadata
Title
Effect of Amiloride on Experimental Acid-Induced Heartburn in Non-erosive Reflux Disease
Authors
William J. Bulsiewicz
Nicholas J. Shaheen
Mark B. Hansen
Amy Pruitt
Roy C. Orlando
Publication date
01-07-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2586-0

Other articles of this Issue 7/2013

Digestive Diseases and Sciences 7/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.